在人类中,L-氨酸和S-酸氨酸会减少栓塞
Z Kaposzta1, P A Baskerville, D Madge
1Clinical Neuroscience, St George's Hospital Medical School, Cranmer Terrace, London.
Circulation
|May 23, 2001
概括
在 carotid endarterectomy 后,L-arginine 和 S-nitrosoglutathione (GSNO) 显著降低了多普勒栓塞信号. 这些发现表明氧化系统在治疗血栓塞栓性疾病中的潜在治疗应用.
科学领域:
- 神经科学是一个神经科学.
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 氨酸显示出抗血小板作用ex vivo,但缺乏临床证据.
- 在 carotid endarterectomy 后通过多普勒超声波检测到的大脑栓塞信号,预测中风复发.
- 酸酸 (GSNO) 是一种具有潜在血小板特异性的氧化供体.
研究的目的:
- 为了评估L-氨酸和GSNO的抗血小板功效.
- 为了确定这些药物是否降低血管栓塞信号后心血管内切除术.
主要方法:
- 随机,双盲,安慰剂对照试验.随机,双盲,安慰剂对照试验.
- 患者在手术后90分钟内接受静脉注射L-阿尔金因,GSNO或安慰剂.
- 在24小时内对中脑动脉栓塞信号进行跨骨多普勒监测.
主要成果:
- 与安慰剂相比,L-氨酸和GSNO都显著降低了多普勒栓塞信号 (P<0.001).
- 在前4小时内血栓信号的中位数:安慰剂44.7,L-氨酸9.5,GSNO0.8.
- 在两个治疗组中,信号减少持续了24小时.
结论:
- 静脉注射L-氨酸和GSNO有效地减弱了人类的多普勒栓塞信号.
- 调节氧化系统可能为血栓塞栓性疾病提供新的治疗方法.
- 多普勒栓塞信号检测是评估抗血小板剂有效性的可行方法.
相关概念视频
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.7K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.7K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
3.0K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
3.0K
Antihypertensive Drugs: Direct Renin Inhibitors
1.9K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.9K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
2.1K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
2.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Antianginal Drugs: Nitrates and β-Blockers
1.9K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.9K


